Guideline for the laboratory diagnosis of functional iron deficiency

Functional iron deficiency (FID) is a state in which there is insufficient iron incorporation into erythroid precursors in the face of apparently adequate body iron stores, as defined by the presence of stainable iron in the bone marrow together with a serum ferritin value within normal limits (Macdougall et al, 1989). In its broadest sense this definition encompasses the partial block in iron transport to the erythroid marrow seen in subjects with infectious, inflammatory and malignant diseases, and is a major component of the anaemia of chronic disease (ACD). One form of FID, found in some subjects treated with erythropoiesis-stimulating agents (ESAs), has been the subject of numerous studies following the widespread use of these agents, especially in subjects with chronic kidney disease (CKD).

[1]  D. Swinkels,et al.  Intra-individual variability of serum hepcidin-25 in haemodialysis patients using mass spectrometry and ELISA. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  J. Adamson,et al.  Notice , 2012, Kidney International Supplements.

[3]  D. Coyne Hepcidin: clinical utility as a diagnostic tool and therapeutic target. , 2011, Kidney international.

[4]  D. Henry Parenteral iron therapy in cancer-associated anemia. , 2010, Hematology. American Society of Hematology. Education Program.

[5]  T. Ganz,et al.  Detection, evaluation, and management of iron-restricted erythropoiesis. , 2010, Blood.

[6]  D. Girelli,et al.  Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  A. Mangione,et al.  A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  I. Macdougall,et al.  Current status of the measurement of blood hepcidin levels in chronic kidney disease. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[9]  M. Rebeschini,et al.  Diagnosis of iron deficiency in patients undergoing hemodialysis. , 2010, American journal of clinical pathology.

[10]  A. Heath,et al.  A WHO Reference Reagent for the Serum Transferrin Receptor (sTfR): international collaborative study to evaluate a recombinant soluble transferrin receptor preparation , 2010, Clinical chemistry and laboratory medicine.

[11]  K. Nitta,et al.  Usefulness of measuring reticulocyte hemoglobin equivalent in the management of haemodialysis patients with iron deficiency , 2010, International journal of laboratory hematology.

[12]  E. Urrechaga The new mature red cell parameter, low haemoglobin density of the Beckman‐Coulter LH750: clinical utility in the diagnosis of iron deficiency , 2010, International journal of laboratory hematology.

[13]  E. Urrechaga Clinical utility of the new beckman‐coulter parameter red blood cell size factor in the study of erithropoiesis , 2009, International journal of laboratory hematology.

[14]  L. Borque,et al.  Potential utility of the new Sysmex XE 5000 red blood cell extended parameters in the study of disorders of iron metabolism , 2009, Clinical chemistry and laboratory medicine.

[15]  Anastasios Koulaouzidis,et al.  Soluble transferrin receptors and iron deficiency, a step beyond ferritin. A systematic review. , 2009, Journal of gastrointestinal and liver diseases : JGLD.

[16]  P. Danise,et al.  Erythrocyte and reticulocyte indices in iron deficiency in chronic kidney disease: comparison of two methods , 2009, Scandinavian journal of clinical and laboratory investigation.

[17]  D. Dietzen,et al.  Reticulocyte hemoglobin content , 2008, American journal of hematology.

[18]  Ajay K. Singh,et al.  Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study. , 2007, Journal of the American Society of Nephrology : JASN.

[19]  G. Zini,et al.  Reticulocyte hemoglobin equivalent: an indicator of reduced iron availability in chronic kidney diseases during erythropoietin therapy. , 2007, Laboratory hematology : official publication of the International Society for Laboratory Hematology.

[20]  T. Ganz Molecular control of iron transport. , 2007, Journal of the American Society of Nephrology : JASN.

[21]  C. Brugnara,et al.  Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states , 2006, Clinical and laboratory haematology.

[22]  D. Tarng,et al.  Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  Kdoqi KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  Kdoqi Disclaimer,et al.  KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  G. Lippi,et al.  Stability of blood cell counts, hematologic parameters and reticulocytes indexes on the Advia A120 hematologic analyzer. , 2005, The Journal of laboratory and clinical medicine.

[26]  J. Linssen,et al.  Reticulocyte hemoglobin measurement – comparison of two methods in the diagnosis of iron-restricted erythropoiesis , 2005, Clinical chemistry and laboratory medicine.

[27]  K. Kalantar-Zadeh,et al.  Time-dependent associations between iron and mortality in hemodialysis patients. , 2005, Journal of the American Society of Nephrology : JASN.

[28]  B. Möller,et al.  Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin , 2005, Annals of Hematology.

[29]  Jerry Kaplan,et al.  Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization , 2004, Science.

[30]  G. Aronoff,et al.  Making sense: a scientific approach to intravenous iron therapy. , 2004, Journal of the American Society of Nephrology : JASN.

[31]  B. Bain,et al.  How should stainable iron in bone marrow films be assessed? , 2004, Journal of Clinical Pathology.

[32]  F. Locatelli,et al.  Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  C. Brugnara,et al.  Iron deficiency and erythropoiesis: new diagnostic approaches. , 2003, Clinical chemistry.

[34]  D. Tarng,et al.  Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[35]  T. Littlewood,et al.  Baseline and early treatment factors are not clinically useful for predicting individual response to erythropoietin in anemic cancer patients. , 2003, The oncologist.

[36]  Yung-Ming Chen,et al.  Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients. , 2002, Clinical nephrology.

[37]  Keith C. Norris,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[38]  Eun Jung Lee,et al.  Soluble transferrin receptor (sTfR), ferritin, and sTfR/log ferritin index in anemic patients with nonhematologic malignancy and chronic inflammation. , 2002, Clinical chemistry.

[39]  Christian Thomas,et al.  Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. , 2002, Clinical chemistry.

[40]  D. Dietzen,et al.  Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiency. , 2002, Blood.

[41]  S. Fishbane,et al.  A randomized trial of iron deficiency testing strategies in hemodialysis patients. , 2001, Kidney international.

[42]  A. Lupo,et al.  The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[43]  A. Tefferi,et al.  A bone marrow report of absent stainable iron is not diagnostic of iron deficiency , 2001, Annals of Hematology.

[44]  K. Abdulkadyrov,et al.  HLA-DR4-Ala74β is associated with risk and poor outcome of severe aplastic anemia , 2001, Annals of Hematology.

[45]  M. Hartmann,et al.  Zinc protoporphyrin and percentage of hypochromic erythrocytes as markers of functional iron deficiency during therapy with erythropoietin in patients with advanced acquired immunodeficiency syndrome. , 1999, Southern medical journal.

[46]  I. Cavill,et al.  Iron status as measured by serum ferritin: the marker and its limitations. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[47]  P. Saavedra-Santana,et al.  Diagnosis of iron deficiency in chronic renal failure. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[48]  S. Schuster,et al.  Serum soluble transferrin receptor and the prediction of marrow aspirate iron results in a heterogeneous group of patients. , 1999, Clinical and laboratory haematology.

[49]  R. Mushnick,et al.  Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[50]  G. Bailie,et al.  Sensitivity and specificity of transferrin saturation and serum ferritin as markers of iron status after intravenous iron dextran in hemodialysis patients. , 1997, Renal failure.

[51]  M. Worwood The laboratory assessment of iron status--an update. , 1997, Clinica chimica acta; international journal of clinical chemistry.

[52]  S. Fishbane,et al.  Iron management in end-stage renal disease. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[53]  K. Punnonen,et al.  Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. , 1997, Blood.

[54]  E. Graham,et al.  Elevated zinc protoporphyrin associated with thalassemia trait and hemoglobin E. , 1996, The Journal of pediatrics.

[55]  L. Lessin,et al.  The use of r‐HuEpo in the treatment of anaemia related to myelodysplasia (MDS) , 1995, British journal of haematology.

[56]  M. Mittelman,et al.  Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. , 1992, Blood.

[57]  J. Cook,et al.  Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia. , 1992, The Journal of laboratory and clinical medicine.

[58]  B. Bain,et al.  Detection of functional iron deficiency during erythropoietin treatment: a new approach. , 1992, BMJ.

[59]  S. Piantadosi,et al.  Decreased erythropoietin response in patients with the anemia of cancer. , 1990, The New England journal of medicine.

[60]  I. Cavill,et al.  Treating renal anaemia with recombinant human erythropoietin: practical guidelines and a clinical algorithm. , 1990, British medical journal.

[61]  I. Cavill,et al.  Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously. , 1989, BMJ.

[62]  M. Hochberg,et al.  Serum immunoreactive erythropoietin in rheumatoid arthritis: impaired response to anemia. , 1988, Arthritis and rheumatism.

[63]  J. Cook,et al.  Serum ferritin: a possible model for the assessment of nutrient stores. , 1982, The American journal of clinical nutrition.

[64]  Majid Ali,et al.  FAILURE OF SERUM FERRITIN LEVELS TO PREDICT BONE-MARROW IRON CONTENT AFTER INTRAVENOUS IRON-DEXTRAN THERAPY , 1982, The Lancet.

[65]  J. Winchester,et al.  Hemosiderosis in hemodialysis patients. , 1981, JAMA.

[66]  D. Malcolm,et al.  Hemosiderosis in hemodialysis patients. An autopsy study of 50 cases. , 1980, JAMA.

[67]  B. Lubin,et al.  The influence of plasma bilirubin on zinc protoporphyrin measurement by a hematofluorimeter. , 1978, The Journal of laboratory and clinical medicine.

[68]  K. Kalantar-Zadeh,et al.  Should we limit the ferritin upper threshold to 500 ng/ml in CKD patients? , 2007, Nephrology news & issues.

[69]  A. Kirschbaum,et al.  The diagnostic plot , 2006, Medical oncology.

[70]  Á. Remacha,et al.  Clinical utility of the new Sysmex XE 2100 parameter - reticulocyte hemoglobin equivalent - in the diagnosis of anemia. , 2005, Haematologica.

[71]  E. Hellström-Lindberg,et al.  Hypochromic red blood cells in low-risk myelodysplastic syndromes: effects of treatment with hemopoietic growth factors. , 2004, Haematologica.

[72]  M. Scott,et al.  Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. , 1998, Clinical chemistry.

[73]  M. Kishino,et al.  Effect of alpha-tocopherol on in vitro and in vivo metabolism of low-density lipoproteins in haemodialysis patients. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[74]  S. Garrett,et al.  Zinc protoporphyrin and iron-deficient erythropoiesis. , 1994, Acta haematologica.

[75]  G Barosi,et al.  Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial. , 1992, Blood.

[76]  P. Pootrakul,et al.  Intact transferrin receptors in human plasma and their relation to erythropoiesis. , 1990, Blood.

[77]  Y. Niitsu,et al.  Serum transferrin receptor as a new index of erythropoiesis. , 1987, Blood.